Related Experiment Video
Updated: Jun 9, 2026

Application of Live Mitochondria Staining in Cell-Sorting to Purify Hepatocytes Derived from Human Induced Pluripotent Stem Cells
Published on: December 1, 2023
From skin cells to hepatocytes: advances in application of iPS cell technology
1Thomas Jefferson University School of Medicine, Philadelphia, Pennsylvania 19107, USA. Linda.greenbaum@jefferson.edu
Abstract:
The discovery several years ago that fibroblasts and other somatic cells from mice and humans can be reprogrammed to become inducible pluripotent stem (iPS) cells has created enthusiasm for their potential applications in regenerative medicine and for modeling human diseases. Two independent studies in this issue of the JCI provide evidence that iPS cells represent a promising source of hepatocytes for a wide range of applications, including cell transplantation, drug toxicity testing, patient-specific disease modeling, and even ex vivo gene therapy. But how far have we come?
Related Concept Videos
iPS Cell Differentiation
Induced Pluripotent Stem Cells
Somatic cells are...
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
EPS and iPS Cells in Disease Research
Somatic to iPS Cell Reprogramming

